Information about Asterion
My details
*
*
*

Company information

Status
Juridical incident

Enterprise number

BE0715.602.553

VAT liability
Yes
Established
07-12-2018
Last balance sheet year
2024
Company size
Micro 0 FTE
Full name
Asterion Therapeutics
Principal activity
Manufacture of other pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Asterion

2024 2023 2022 2021
Profit/Loss -23,265 -72 % -14,814 43 % -13,550 9 % -25,842
Equity -118,619 -20 % -113,534 -33 % -98,720 13 % -85,170
Gross margin -12,786 -56 % -9,064 49 % -8,195 10 % -17,865

Publications from Asterion

Date Publication
24-12-2020 Resignations - Appointments (NL)
09-01-2020 Registered Office (NL)
11-12-2018 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Asterion Therapeutics?
The VAT number of Asterion Therapeutics is BE 0715.602.553.
Wat is the PEPPOL ID of Asterion Therapeutics?
The PEPPOL ID of Asterion Therapeutics is 0208:0715602553. Log in or start a free trial to see the full overview.
When was Asterion Therapeutics founded?
Asterion Therapeutics was founded on 07-12-2018.
What is the address of Asterion Therapeutics?
The current registered office of Asterion Therapeutics is located at Frans De Cortlaan 3/1, 2610 Antwerpen.
When was the last time Asterion Therapeutics filed their annual financial statements?
The most recent financial statements of Asterion Therapeutics were filed on 03-10-2025.
How many employees does Asterion Therapeutics have?
There are currently no employees working at Asterion Therapeutics or no workforce information is available.
What is the annual turnover of Asterion Therapeutics?
At the time of its most recent financial statements, Asterion Therapeutics did not publish any turnover figures. Asterion Therapeutics reported a gross margin of -€12,786.00.